{"id":"humulin-l","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Humulin L (insulin zinc suspension) is a basal insulin formulation that provides prolonged glycemic control by mimicking endogenous insulin secretion. It works by binding to insulin receptors on muscle and adipose tissue, promoting glucose uptake and storage while suppressing hepatic glucose production. The zinc suspension formulation extends the duration of action compared to regular insulin.","oneSentence":"Humulin L is a long-acting insulin that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:47:32.000Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT04542148","phase":"PHASE2","title":"Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-02-10","conditions":"Diabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk","enrollment":120},{"nctId":"NCT07485101","phase":"NA","title":"Glycemic Targets During CPB in Elderly Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-04-01","conditions":"Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery","enrollment":3000},{"nctId":"NCT07329088","phase":"NA","title":"Isoleucine Addition Treatment Effects in a Controlled Diet Study","status":"NOT_YET_RECRUITING","sponsor":"Jean L. Fry","startDate":"2026-05-04","conditions":"Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Metabolic Syndrome (MetS), Obesity & Overweight","enrollment":40},{"nctId":"NCT06686329","phase":"NA","title":"Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose","status":"RECRUITING","sponsor":"Jane Yardley","startDate":"2025-03-17","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT04876079","phase":"NA","title":"Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2021-06-01","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT05821322","phase":"NA","title":"Blood Glucose Target Before and During Exercise in Adults With Type 1 Diabetes Using an Artificial Pancreas","status":"TERMINATED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2023-07-01","conditions":"Type 1 Diabetes","enrollment":6},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT07408479","phase":"NA","title":"Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance","status":"RECRUITING","sponsor":"Mondelēz International, Inc.","startDate":"2025-11-15","conditions":"Insulin Resistance","enrollment":40},{"nctId":"NCT06330194","phase":"NA","title":"Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-04-18","conditions":"Dialysis, Chronic Kidney Disease, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT07376850","phase":"NA","title":"Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Motol","startDate":"2026-01","conditions":"Diabetes, Diabetes (DM), Diabetes Type 1","enrollment":120},{"nctId":"NCT04614168","phase":"NA","title":"Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-07-26","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia","enrollment":24},{"nctId":"NCT03877939","phase":"","title":"Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy","status":"COMPLETED","sponsor":"Vida Recoletas Sevilla","startDate":"2019-09-15","conditions":"Non-Viable Pregnancy","enrollment":433},{"nctId":"NCT04809688","phase":"NA","title":"Saskatoon Berry on Metabolism and Gut Microbiota in Healthy Subjects","status":"ENROLLING_BY_INVITATION","sponsor":"University of Manitoba","startDate":"2023-01-08","conditions":"Nutritional and Metabolic Diseases","enrollment":20},{"nctId":"NCT07298304","phase":"NA","title":"Impact of Sorghum Rice on Beta-Cell Function and Insulin Resistance in Prediabetes","status":"COMPLETED","sponsor":"Dr. Soetomo General Hospital","startDate":"2022-03-01","conditions":"Prediabetic State, Glucose Intolerance, Insulin Resistance","enrollment":26},{"nctId":"NCT06592261","phase":"PHASE1","title":"Graded Insulin Suppression Test P&F","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-09-16","conditions":"Insulin Resistance, Hyperinsulinemia, Obesity","enrollment":15},{"nctId":"NCT06547619","phase":"EARLY_PHASE1","title":"Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM","status":"RECRUITING","sponsor":"Anna Stanhewicz, PhD","startDate":"2024-10-01","conditions":"Gestational Diabetes, Endothelial Dysfunction, Physical Inactivity","enrollment":40},{"nctId":"NCT03422848","phase":"NA","title":"Hydration to Optimize Metabolism","status":"COMPLETED","sponsor":"Region Skane","startDate":"2018-04-24","conditions":"Glucose, High Blood","enrollment":797},{"nctId":"NCT05514535","phase":"PHASE3","title":"A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-08-29","conditions":"Diabetes Mellitus, Type 2, Obesity","enrollment":568},{"nctId":"NCT04225455","phase":"","title":"The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Surrey","startDate":"2019-12-05","conditions":"Insulin Dependent Diabetes","enrollment":17},{"nctId":"NCT05259449","phase":"NA","title":"Efficacy of Educational Nutrition and Exercise on the Regulation of Appetite Through Exosomes in Type 2 Diabetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cadiz","startDate":"2022-03-10","conditions":"Diabetes Mellitus, Type 2","enrollment":146},{"nctId":"NCT03610178","phase":"NA","title":"Genetic and Epigenetic Mechanisms of Developing Gestational Diabetes Mellitus and Its Effects on the Fetus","status":"COMPLETED","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2015-08","conditions":"Gestational Diabetes Mellitus","enrollment":850},{"nctId":"NCT07237841","phase":"NA","title":"Preoperative Carbohydrate Loading in Diabetes Mellitus","status":"COMPLETED","sponsor":"Gia Dinh People Hospital","startDate":"2023-03-01","conditions":"Type2diabetes, Enhanced Recovery After Surgery (ERAS), Fasting","enrollment":76},{"nctId":"NCT05251207","phase":"NA","title":"Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Poznan University of Physical Education","startDate":"2022-02-07","conditions":"Insulin Resistance","enrollment":40},{"nctId":"NCT05114590","phase":"PHASE4","title":"Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2022-01-27","conditions":"Type 2 Diabetes Mellitus","enrollment":124},{"nctId":"NCT06238778","phase":"PHASE2","title":"Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diasome Pharmaceuticlas, Inc.","startDate":"2024-01-23","conditions":"Diabetes Mellitus, Type 1","enrollment":227},{"nctId":"NCT02244073","phase":"NA","title":"Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2015-05","conditions":"Critical Illness","enrollment":2069},{"nctId":"NCT06605872","phase":"","title":"DigiDiab Pilot: Impact Study Hospital","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2025-04-01","conditions":"Type 2 Diabetes","enrollment":500},{"nctId":"NCT07097987","phase":"NA","title":"Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion","status":"NOT_YET_RECRUITING","sponsor":"TCI Co., Ltd.","startDate":"2025-08-31","conditions":"Obesity","enrollment":14},{"nctId":"NCT07094529","phase":"NA","title":"Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2025-07-21","conditions":"Type 2 Diabetes (T2DM), Hypoglycemia (Diabetic)","enrollment":120},{"nctId":"NCT06422494","phase":"NA","title":"The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2025-01-01","conditions":"Diabetes Mellitus, Type 1, Inflammation","enrollment":24},{"nctId":"NCT07082062","phase":"NA","title":"Effects of GLP-1 Formula on GLP-1 and Glucose Regulation","status":"RECRUITING","sponsor":"Shih Chien Huang","startDate":"2025-06-02","conditions":"Overweight","enrollment":100},{"nctId":"NCT06412497","phase":"PHASE2","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-06-05","conditions":"Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia","enrollment":60},{"nctId":"NCT06668714","phase":"NA","title":"Does Co-administration of Lactate Affect Postprandial Nutrient Absorption and Fat Disposition?","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-08-22","conditions":"Pre Diabetes, Metabolic Syndrome","enrollment":25},{"nctId":"NCT07014735","phase":"NA","title":"Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM","status":"RECRUITING","sponsor":"Richmond Pharmacology Limited","startDate":"2023-04-13","conditions":"Diabetes Type 2, Hyperglycaemia (Diabetic), QT Interval, Variation in","enrollment":24},{"nctId":"NCT05946785","phase":"EARLY_PHASE1","title":"Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes","status":"RECRUITING","sponsor":"Anna Stanhewicz, PhD","startDate":"2023-07-01","conditions":"Gestational Diabetes, Vascular Endothelial Function","enrollment":28},{"nctId":"NCT05946798","phase":"EARLY_PHASE1","title":"Role of NADPH Oxidase in Microvascular Dysfunction Following GDM","status":"RECRUITING","sponsor":"Anna Stanhewicz, PhD","startDate":"2023-08-30","conditions":"Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function","enrollment":40},{"nctId":"NCT01528189","phase":"NA","title":"Effect of High Dose Insulin on Infectious Complications Following Major Surgery","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-10-05","conditions":"Surgical Site Infection After Major Surgery","enrollment":460},{"nctId":"NCT06962410","phase":"NA","title":"Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-04-01","conditions":"Diabetes Mellitus Patients With Kidney Transplantation","enrollment":30},{"nctId":"NCT06941675","phase":"NA","title":"Hybrid Closed-Loop System in LADA Patients: A Randomized Trial","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-04-01","conditions":"Latent Autoimmune Diabetes in Adults (LADA)","enrollment":50},{"nctId":"NCT03305549","phase":"NA","title":"Recovery After Dialysis-Requiring Acute Kidney Injury","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2017-09-29","conditions":"Acute Kidney Injury","enrollment":16},{"nctId":"NCT04979377","phase":"","title":"Prevalence of Hyperandrogenism in Type 1 Diabetes","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2020-03-09","conditions":"Type 1 Diabetes, Polycystic Ovary Syndrome, Hyperandrogenism","enrollment":150},{"nctId":"NCT05306028","phase":"PHASE2","title":"Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fudan University","startDate":"2022-08-01","conditions":"Pancretic Cancer, Diabete Mellitus","enrollment":20},{"nctId":"NCT06825182","phase":"PHASE3","title":"Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-11-07","conditions":"Type 2 Diabetes Mellitus","enrollment":1000},{"nctId":"NCT06793904","phase":"NA","title":"Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-02-01","conditions":"Polycystic Ovarian Syndrome (PCOS)","enrollment":122},{"nctId":"NCT06638567","phase":"NA","title":"Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.","status":"RECRUITING","sponsor":"Abraham Hulst, MD, PhD","startDate":"2025-01-03","conditions":"Diabetes Mellitus, Type 2, Surgical Site Infection","enrollment":1008},{"nctId":"NCT06755788","phase":"NA","title":"Effects of Intraoperative Glycemic Management Strategies Assisted with RT-CGM on TIR and Postoperative Recovery","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-12-25","conditions":"Continuous Glucose Monitoring","enrollment":246},{"nctId":"NCT06739473","phase":"PHASE4","title":"Total-body Glucose Utilization in Obesity","status":"RECRUITING","sponsor":"Turku University Hospital","startDate":"2023-01-25","conditions":"Obesity and Overweight","enrollment":60},{"nctId":"NCT06126419","phase":"NA","title":"Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2023-11-08","conditions":"Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration","enrollment":70},{"nctId":"NCT04702672","phase":"NA","title":"High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2023-01-01","conditions":"Type 2 Diabetes","enrollment":38},{"nctId":"NCT06686069","phase":"NA","title":"Effect of Oral L-arginine 3.32 g a Day on Oxidative Stress Influencing Beta Cell Function and Insulin Resistance.","status":"NOT_YET_RECRUITING","sponsor":"Federico II University","startDate":"2025-01-18","conditions":"Diabetes, Pre-diabetes, Metabolic Syndrome","enrollment":42},{"nctId":"NCT04067752","phase":"NA","title":"Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2022-03-01","conditions":"End-stage Renal Disease","enrollment":18},{"nctId":"NCT06061926","phase":"PHASE2","title":"Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion","status":"RECRUITING","sponsor":"University of Guadalajara","startDate":"2023-05-20","conditions":"Metabolic Syndrome","enrollment":28},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT04852523","phase":"EARLY_PHASE1","title":"18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-09-16","conditions":"Pancreatitis, Graft, Pancreatic Transplant Post-Transplant Dysfunction Rejection","enrollment":4},{"nctId":"NCT06178874","phase":"NA","title":"Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-12-01","conditions":"Glycemic Control, Insulin, Critical Illness","enrollment":90},{"nctId":"NCT06056167","phase":"NA","title":"Degludec Insulin Use in Critically Ill Patients","status":"COMPLETED","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2023-05-17","conditions":"Diabetes Mellitus, Critical Illness, Hyperglycemia","enrollment":155},{"nctId":"NCT03437330","phase":"PHASE4","title":"Empagliflozin Effect on Glucose Toxicity","status":"WITHDRAWN","sponsor":"University Hospital Tuebingen","startDate":"2021-10-27","conditions":"Type2 Diabetes Mellitus","enrollment":""},{"nctId":"NCT06405243","phase":"PHASE3","title":"Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients","status":"NOT_YET_RECRUITING","sponsor":"Beni-Suef University","startDate":"2024-06-30","conditions":"Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT04909333","phase":"NA","title":"Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-04-29","conditions":"Endogenous Hyperinsulinism","enrollment":29},{"nctId":"NCT04011020","phase":"PHASE2, PHASE3","title":"Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes","status":"RECRUITING","sponsor":"Throne Biotechnologies Inc.","startDate":"2022-09-20","conditions":"Type 1 Diabetes","enrollment":50},{"nctId":"NCT05808972","phase":"PHASE4","title":"0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis","status":"COMPLETED","sponsor":"Tunis University","startDate":"2022-11-01","conditions":"Metabolic Ketoacidosis, Ketoacidemia, Acetonemia","enrollment":92},{"nctId":"NCT05770076","phase":"NA","title":"Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)","status":"COMPLETED","sponsor":"Bogomolets National Medical University","startDate":"2023-02-01","conditions":"Obesity, Obesity, Abdominal, Insulin Resistance","enrollment":55},{"nctId":"NCT05585801","phase":"NA","title":"Continuous Glucose Monitoring in Intensive Care Unit","status":"RECRUITING","sponsor":"Institute for Clinical and Experimental Medicine","startDate":"2022-11-01","conditions":"Blood Glucose, Critical Care","enrollment":500},{"nctId":"NCT04623086","phase":"PHASE4","title":"Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose","status":"COMPLETED","sponsor":"University of Washington","startDate":"2020-02-14","conditions":"Type 1 Diabetes","enrollment":59},{"nctId":"NCT06251895","phase":"","title":"Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Jahra Hospital","startDate":"2021-08-01","conditions":"Diabetic Ketoacidosis","enrollment":241},{"nctId":"NCT06176599","phase":"NA","title":"Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis","status":"UNKNOWN","sponsor":"Lin Liao","startDate":"2022-09-01","conditions":"Diabetic Kidney Disease","enrollment":60},{"nctId":"NCT02622854","phase":"NA","title":"Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-06","conditions":"Acute Pancreatitis","enrollment":22},{"nctId":"NCT06065930","phase":"","title":"Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS)","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2023-05-05","conditions":"Obesity, Type 2 Diabetes","enrollment":45},{"nctId":"NCT03530189","phase":"","title":"Outcome of Very Preterm Infants With Glucose Level Disturbances","status":"COMPLETED","sponsor":"University Hospital Rijeka","startDate":"2018-01-01","conditions":"Cerebral Palsy Infantile","enrollment":150},{"nctId":"NCT05973734","phase":"PHASE1","title":"Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2023-10-01","conditions":"Islet Transplantation","enrollment":24},{"nctId":"NCT02036372","phase":"NA","title":"Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-01","conditions":"Diabetes Mellitus Type II","enrollment":150},{"nctId":"NCT05908877","phase":"","title":"Cardio-Metabolic Risk Evaluation in Overweight and Obese Children","status":"UNKNOWN","sponsor":"Neoped - Centru de Pediatrie","startDate":"2023-07-10","conditions":"Pediatric Obesity, Metabolic Syndrome, Nonalcoholic Fatty Liver","enrollment":50},{"nctId":"NCT04939792","phase":"EARLY_PHASE1","title":"Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans","status":"COMPLETED","sponsor":"Louisiana State University Health Sciences Center Shreveport","startDate":"2020-11-06","conditions":"Vitamin D Deficiency","enrollment":165},{"nctId":"NCT00636714","phase":"PHASE4","title":"Comparison of 2 Methods to Achieve Tight Glucose Control in Cardiovascular ICU Patients","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2008-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":40},{"nctId":"NCT05095259","phase":"NA","title":"Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes","status":"UNKNOWN","sponsor":"Nordsjaellands Hospital","startDate":"2019-12-16","conditions":"Type1diabetes","enrollment":60},{"nctId":"NCT05810883","phase":"","title":"Prevalence of IR in Overweight and Obese Adolescents","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-05-11","conditions":"Insulin Resistance","enrollment":50},{"nctId":"NCT02621489","phase":"PHASE4","title":"Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2015-12","conditions":"Atherosclerosis, Diabetes, Restenosis","enrollment":38},{"nctId":"NCT02032953","phase":"PHASE4","title":"Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2013-12","conditions":"Colorectal Cancer","enrollment":24},{"nctId":"NCT03053089","phase":"PHASE1, PHASE2","title":"Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I","status":"COMPLETED","sponsor":"ArmaGen, Inc","startDate":"2015-10","conditions":"Mucopolysaccharidosis I","enrollment":21},{"nctId":"NCT03071341","phase":"PHASE1, PHASE2","title":"Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I","status":"COMPLETED","sponsor":"ArmaGen, Inc","startDate":"2016-10","conditions":"Mucopolysaccharidosis I","enrollment":19},{"nctId":"NCT05743751","phase":"NA","title":"Normothermic Machine Perfusion (NMP) Versus Hypothermic Machine Perfusion (HMP) in Human Kidney Transplantation","status":"UNKNOWN","sponsor":"Zhang Tianyu","startDate":"2023-03-03","conditions":"Kidney Transplantation","enrollment":60},{"nctId":"NCT02371226","phase":"PHASE1","title":"Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I","status":"COMPLETED","sponsor":"ArmaGen, Inc","startDate":"2015-07","conditions":"Mucopolysaccharidosis I","enrollment":3},{"nctId":"NCT04765982","phase":"NA","title":"Does Insulin Requirement Post Cardiac Surgery Predicts The Risk Of Developing Diabetes","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2021-12-01","conditions":"Diabetes, Pre-diabetes","enrollment":100},{"nctId":"NCT04673656","phase":"NA","title":"Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"BioKier Inc.","startDate":"2021-04-18","conditions":"Type 2 Diabetes","enrollment":60},{"nctId":"NCT05695651","phase":"","title":"Association of Triglyceride Glucose Index and HOMA IR as Predictors of Vascular Complications of DM Type 2","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-02-07","conditions":"Type 2 Diabetes Mellitus","enrollment":56},{"nctId":"NCT05308095","phase":"NA","title":"The HEADWIND Study - Part 4","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2022-04-13","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT05576740","phase":"","title":"Influence of Menstrual Cycle Stages on Female Athletes","status":"COMPLETED","sponsor":"Universitat Jaume I","startDate":"2022-03-16","conditions":"Menstrual Cycle, Sports","enrollment":41},{"nctId":"NCT04352738","phase":"","title":"Role of the Liver in Glucose Homeostasis Using Metabolic Imaging","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-04-15","conditions":"Type 1 Diabetes, Bariatric Surgery Candidate","enrollment":30},{"nctId":"NCT03689374","phase":"PHASE3","title":"A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-10-01","conditions":"Diabetes Mellitus, Type 2","enrollment":2274},{"nctId":"NCT05292300","phase":"NA","title":"Efficacy of Lyophilized Dried Cornus Mas L. on Anthropometric and Biochemical Parameters in Insulin Resistance","status":"COMPLETED","sponsor":"Marmara University","startDate":"2021-05-24","conditions":"Insulin Resistance, Obesity, PreDiabetes","enrollment":84},{"nctId":"NCT04886973","phase":"NA","title":"Effect of Insulin Resistance on Branched Chain Amino Acid Metabolism.","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Obesity, Insulin Resistance","enrollment":40},{"nctId":"NCT05270343","phase":"PHASE3","title":"Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2022-06-01","conditions":"Type 1 Diabetes","enrollment":198},{"nctId":"NCT05355285","phase":"NA","title":"Type 1 Diabetes and Depression: Role of Brain Glutamate","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2011-01","conditions":"Type1diabetes, Depressive Symptoms, Major Depressive Disorder","enrollment":68},{"nctId":"NCT05183191","phase":"NA","title":"The HEADWIND Study - Part 3","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-11-29","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":11}],"_emaApprovals":[],"_faersSignals":[{"count":179,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":123,"reaction":"BLOOD GLUCOSE DECREASED"},{"count":48,"reaction":"MALAISE"},{"count":48,"reaction":"NAUSEA"},{"count":47,"reaction":"HYPOGLYCAEMIA"},{"count":46,"reaction":"PHARMACEUTICAL PRODUCT COMPLAINT"},{"count":44,"reaction":"DRUG INEFFECTIVE"},{"count":43,"reaction":"BLOOD GLUCOSE FLUCTUATION"},{"count":43,"reaction":"LOSS OF CONSCIOUSNESS"},{"count":43,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Humulin L","genericName":"Humulin L","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Humulin L is a long-acting insulin that binds to insulin receptors to facilitate glucose uptake and utilization in peripheral tissues. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}